In hepatocellular carcinoma, elevated plasma levels of SERPINE1 in patients with the 4G/4G polymorphism was found to be associated with reduced survival after transcatheter arterial chemoembolization, compared to patients with 5G/5G or 4G/5G genotype [16]. Here, SERPINE1 is linked to hepatocellular carcinoma.